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Background: Muscle development and remodelling, mitochondrial physiology and inflammation are thought to be
inter-related and to have implications for metabolism in both health and disease. However, our understanding of
their molecular control is incomplete.
Results: In this study we have confirmed that the ring finger 14 protein (RNF14), a poorly understood transcriptional
regulator, influences the expression of both mitochondrial and immune-related genes. The prediction was based on a
combination of network connectivity and differential connectivity in cattle (a non-model organism) and mice data sets,
with a focus on skeletal muscle. They assigned similar probability to mammalian RNF14 playing a regulatory role in
mitochondrial and immune gene expression. To try and resolve this apparent ambiguity we performed a genome-wide
microarray expression analysis on mouse C2C12 myoblasts transiently transfected with two Rnf14 transcript
variants that encode 2 naturally occurring but different RNF14 protein isoforms. The effect of both constructs was
significantly different to the control samples (untransfected cells and cells transfected with an empty vector). Cluster
analyses revealed that transfection with the two Rnf14 constructs yielded discrete expression signatures from each
other, but in both cases a substantial set of genes annotated as encoding proteins related to immune function were
perturbed. These included cytokines and interferon regulatory factors. Additionally, transfection of the longer transcript
variant 1 coordinately increased the expression of 12 (of the total 13) mitochondrial proteins encoded by the
mitochondrial genome, 3 of which were significant in isolated pair-wise comparisons (Mt-coxII, Mt-nd2 and mt-nd4l).
This apparent additional mitochondrial function may be attributable to the RWD protein domain that is present only in
the longer RNF14 isoform.
Conclusions: RNF14 influences the expression of both mitochondrial and immune related genes in a skeletal muscle
context, and has likely implications for the inter-relationship between bioenergetic status and inflammation.
Keywords: Mitochondria, Inflammation, RNF14, Muscle, NetworksBackground
We are interested in understanding the regulation of
muscle metabolism and its inter-relationships with de-
velopment, exercise and ageing. A particular focus is the
regulation of mitochondrial content which is reported to
impact on metabolic syndrome in humans [1] and rats
[2], feed efficiency in livestock [3] and mammalian ageing
[4]. Mitochondrial content also contributes to athletic per-
formance [5] and post-mortem meat quality [6] through* Correspondence: nick.hudson@csiro.au
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reproduction in any medium, provided the orthe connection to muscle fibre type. The physiological
connection between inflammation and muscle biology in
the context of training, muscle remodelling and ageing is
also of interest. For example, during exercise, muscle is
routinely subject to various stressors, such as mechanical
damage, hypoxia and pH decline that set in motion a pro-
inflammatory cascade [7-9] which has implications for
tissue remodelling. Previously, using a network science ap-
proach in cattle [10] we identified the product of the ring
finger protein (RNF14) gene (aliases ARA54, TRIAD2), an
incompletely characterised transcriptional regulator, as a
factor that might influence not only mitochondrial tran-
scription and function but also immune function. In this
study we aimed to explore and validate the accuracy ofl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perimental conditions afforded by in vitro cell culture.
A major foundation of our predicted function of the
RNF14 protein was a bovine co-expression network [10].
Various metabolic and developmental processes were
prioritised for further scrutiny on the basis of forming
cohesive co-expression network gene sets or ‘modules.’
To build the network, bovine muscle sampled at different
times during pre- and post-natal development, between
genetically divergent breeds and following nutritional
intervention, were subject to microarray analysis. By hunt-
ing in the module of interest for transcriptional regulators
(DNA binding transcription factors and co-factors), or
asking the related question “which transcriptional regula-
tor has the highest absolute, average correlation to all the
genes in the module?”, we generated a ranked list of regu-
lators predicted to control the processes in question.
These approaches correctly identified groups of genes
already known to play a role in mammalian skeletal
muscle biology, including master regulators of the cell
cycle (E2F1), fast twitch muscle development (SIX1) and
mitochondrial biogenesis (ESRRA) [10]. Several regula-
tory molecules of unassigned or poorly documented
function were also implicated in some of these pro-
cesses, and they became candidates for future gene func-
tion validation efforts. While most genes are clearly
defined within the network, one prominent gene, Ring
Zinc Finger 14 (RNF14) a transcriptional co-activator
known to bind the androgen receptor [11], gave appar-
ently ambiguous results. Namely, it was assigned likely
roles in two different processes by our analysis – im-
mune function and mitochondrial function [10]. Given
that the majority of connections in the co-expression
network are positive, the prediction is that an increase in
the activity of the ‘regulator’ will increase the expression
of the ‘target’ genes.
A separate analysis on a different data set used a dif-
ferential network strategy called Regulatory Impact Fac-
tor analysis (RIF) [12] to contrast mitochondrial-rich
brown fat versus mitochondrial-poor white fat in mice.
This analysis independently assigned high likelihood to a
causal role for Rnf14 in driving the phenotype differ-
ences between these cell types, also suggestive of a role
in mitochondrial function and content [13]. Little is
known of the function of the RNF14 protein, other than
it is broadly expressed across tissues [14] and is a tran-
scriptional co-activator that interacts with the androgen
receptor transcription factor in pathways relating to sex
steroid signalling. From a structural perspective, there
are six RNF14 transcript variants in humans and three
in mouse, in both cases producing two different protein
isoforms.
The objective of this study was to characterise the
regulatory role of two RNF14 isoforms in mouse muscle.We achieved this via experimental upregulation followed
by functional analysis of the subsequent genome-wide
transcriptional readout. We performed a transient trans-
fection of transcript variants encoding the two different
isoforms in mouse C2C12 cells. The resultant gene ex-
pression perturbations in a number of chemokines, Inter-
feron Regulatory Factors and related interferon signalling
molecules support a role for Rnf14 in skeletal muscle-
mediated immune and inflammatory function. Addition-
ally, the longer transcript variant 1, which encodes a
protein isoform containing an RWD domain, yielded a
coordinate upregulation trend of all mitochondrially-
encoded mitochondrial proteins present on the array plat-




PCR resulted in two differently sized Rnf14 amplicons
from mouse muscle cDNA. These amplicons were indi-
vidually cloned and sequenced. In both cases the se-
quences exhibited >99% sequence identity to the GenBank
Rnf14 sequence. The longer sequence was 1457 bp and
BLASTN aligned this sequence to the Mus musculus
Rnf14 transcript variant 1. The shorter sequence we amp-
lified was 1306 bp, and this was aligned by BLASTN to
the Mus musculus Rnf14 transcript variant 3 (summarised
in Figure 1).
Rnf14 transcript variant 1 contains an ORF capable of
producing E3 ubiquitin protein ligase RNF14 protein
isoform A and Rnf14 transcript variant 3 the ORF for E3
ubiquitin protein ligase RNF14 protein isoform B. The
two isoforms are identical at the C-terminus end of the
protein, while the longer isoforms has an RWD domain
at the N-terminus end not present on the shorter iso-
form. Variant 2 does not encode a protein.
Microarray expression measurements
The array platform used to interrogate the C2C12 re-
sponse to transfection measures genome-wide transcrip-
tional changes using 18,129 probes. This platform contains
three probes predicted to bind Rnf14; ILMN_2675078,
ILMN_2682811, ILMN_2868579. Their proposed binding
sites are illustrated on Figure 1. Probe ILMN_2675078 was
elevated ~3.4-fold in the variant 3 transfected cells and
1.1-fold in the variant 1 transfected cells. This 3.4-fold
change made Rnf14 the 9th most differentially expressed
(DE) gene found in cells transfected with variant 3 out of
the 18,129 probes with detectable signals in at least one
treatment. Correcting for an overall transfection efficiency
of ~10% implies that an individual transfected cell showed
an increase in expression of 34-fold and 11-fold respectively.
The other two Rnf14 probes did not report a change
in expression of Rnf14 following transfection, including
Figure 1 The structures of the three Mus musculus Rnf14
transcript variants and their encoded proteins. Numbers denote
exons. The binding sites for the three Agilent probes, ILMN_2675078,
ILMN_2682811 and ILMN_2868579 are indicated. Also highlighted are
the qRT-PCR primers designed to amplify all Rnf14 species including
the transfection construct derived transcripts, and the primer set for
amplifying endogenous Rnf14 only. The forward primers for amplifying
the transfection construct derived transcripts are indicated; the location
of reverse primer is not shown as it was designed in vector sequence
downstream of the stop codon in exon 11. The dotted red lines
denote beginning and the end of the Open Reading Frames. The *
denotes the position of the first base of the amplified sequence
inserted into the two transfection expression constructs. Solid blue
lines indicate location and size of sequence inserted into the expression
constructs. The RWD domain present on isoform A (translated from the
variant 1 transcript) but not isoform B (translated from the variant 3
transcript) is also highlighted. The Rnf14 variant 2 transcript does not
give rise to a protein.
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not transcript variant 3 (Table 1). It is not clear whether
these 2 probes are reporting correctly. To unravel these
observations and to further document the technical
implentation of the Rnf14 transfections we performed
qRT-PCR on the RNA prepared from the transfected
C2C12 cultures using primers designed to detect the
transfection construct produced mRNA and endogenous
forms of Rnf14 mRNA.
qRT-PCR expression measurements
To compare and contrast the Rnf14 transcript variants
in the different treatment groups, we designed a set of
discriminatory qRT-PCR primers (Table 2). The ANOVA
model for the analysis of Ct values from the qPCRTable 1 Altered expression of Rnf14 transcripts in the Rnf14 va
the three Illumina Rnf14 probes




ILMN_2675078 10.54 ± 0.11 9.02 ± 0.10
ILMN_2682811 7.44 ± 0.13 7.65 ± 0.13
ILMN_2868579 12.73 ± 0.17 12.72 ± 0.17
Assuming a transfection efficiency of ~10%, the fold-changes for the transfected ce
The location of the probes in the different Rnf14 transcripts is given in Figure 1.experiments accounted for 93.03% of the total variation.
The two main effects (primer and treatment) and their
interaction were all highly significant (P < 0.0001).
The normalised expression results are summarised in
Table 3. All primer sets yielded unique dissociation
curves indicating the presence of Rnf14 transcripts in the
anticipated samples. The no template controls yielded no
product in all cases. The transfection of Rnf14 variant 3
was clearly evident in the variant 3 transfected cells but
not the other C2C12 cultures (P < 0.0001). The transcrip-
tional output of this expression construct was also clearly
detectable in the primer set that amplifies all Rnf14
mRNA species (i.e. endogenous and construct-based)
yielding a 30-fold increase (P < 0.0001). The disparity be-
tween this result and the array fold-change is presumably
attributable to the enhanced sensitivity of qRT-PCR.
Similarly, the transfection of the Rnf14 variant 1 was
also clearly detectable in the variant 1 transfected cells
but not the other cell cultures (P < 0.0001). The expres-
sion by the construct was not as effective as for variant
3 and was not reflected in increased amplification by the
all Rnf14 species (endogenous plus construct based) pri-
mer set, presumably because it forms a much more
modest proportion of all the Rnf14 mRNA species in the
system. There was very little variability in native Rnf14
expression (i.e. all three endogenous variants summed)
across the three treatment groups. Overall, these find-
ings imply the global transcriptional readout in the
transfected C2C12 cells described by the microarray
platform can be attributed to the impact of the transfec-
tion of the Rnf14 variants.
Functional enrichment analyses
With regard to the microarray analysis, a mixed-model
normalisation procedure was applied to the raw intensity
values, as previously described [15]. Clustering on col-
umns discriminates the treatments based on global
considerations of the gene expression patterns. The visu-
alisation of the clustering analysis indicated that two of
the six control samples were outliers and hence were re-
moved for the subsequent DE analysis. Overall, the global
gene expression patterns in the two control groups (no









8.78 ± 0.13 3.36 1.17
7.53 ± 0.14 No change No change
12.73 ± 0.08 No change No change
lls are ~33-fold and 12-fold on a per cell basis (based on ILMN_2675078).
Table 2 qRT-PCR primers used to detect endogenous and transfection constructed transcribed Rnf14 mRNA species
Transcripts 5'primer 3'primer
Rnf14 all endogenous and all transfection construct ctcaactgtccagagccaca catggtaccaccaggctctt
Rnf14 all endogenous only gccccattgtgttctcaact gagccatgatgctcttcaca
Rnf14 variant 1 transfection construct aattgaggaggacgacgatg aggaactgcttccttcacga
Rnf14 variant 3 transfection construct aattgaggaggacgacgatg cgtagaatcgagaccgagga
Actb gtgggccgccctaggcaccag ctctttgatgtcacgcacgatttc
Transciption from the Actb gene was used as a control. A schematic of the known mouse Rnf14 mRNA species is presented in Figure 1.
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expression values for the two control groups were com-
bined to form a single control for the purposes of comput-
ing DE between controls and treatments. The Rnf14
variant 3 and 1 transfected cells were both clustered separ-
ately to the controls (more so) and separate to each other
(less so).
We computed a list of DE genes (Tables 4 and 5) as
previously described [16], performing the analysis at the
probe level. To explore the genome-wide expression out-
put for functional enrichment we determined statistically
significant DE for each treatment contrast. We then sub-
mitted the DE lists versus a background list of all genes
present on the array to the GOrilla webtool [17], which
uses hypergeometric statistics to determine functional
enrichments.
With regard to upregulation following over-expression
of the shorter variant 3, “response to biotic stimulus”,
“chemokine activity” and “extracellular region” gave P-
values of 8.44E-12, 2.93E-7 and 7.4E-14 for the Process,
Function and Component ontological levels respectively.
With regard to upregulation following over-expression
of the longer variant 1, the top functional enrichments
were “immune response,” chemokine activity” and “extra-
cellular region” with hypergeometric P-values of 1.98 E-9,
3.83 E-6 and 2.06 E-10.
Various extracellular region components were clearly
among the most downregulated genes following trans-
fection with both variants (Table 5). The enrichment
was highly significant in both cases, but more significant
in the transcript 3 (P = 3.69 E-19) compared to the tran-
script 1 transfected cells (P = 1.32 E-14).
Contrasting effects of the variant 1 transfection with
that of the variant 3 transfection yielded similar functionalTable 3 Expression (Ct LSM) of each Rnf14 mRNA species and
transfected C2C12 cells




Transfected variant 3 20.17 26.73
Transfected variant 1 24.89 26.92
The standard error is 0.447 in all cases because we performed a system-wide norma
amplification.enrichments of “response to biotic stimulus” (3.94E-8), sig-
nal transducer activity (2.15E-4) and extracellular region
(1.77E-5). The identity of the perturbed genes is further il-
lustrated on Figure 2 and tabulated on Tables 4 and 5.
The normalised mean expression results for the entire
data set are in Additional file 1. Transfection with the
empty construct could not be discriminated from untrans-
fected cells, ruling out the possibility that these responses
are an experimental artefact relating to the presence of the
construct. The overall spread of the perturbed transcripts
is greater (4-fold DE in both directions) in the variant 3
transfected cells, which may reflect the greater abundance
of the variant 3 based construct.
We also computed a modified DE metric called
Phenotypic Impact Factors (PIF) [12,13], a product of
the average abundance of the gene and its DE. We have
previously found that this accounts for the increased
noise of the rarer transcripts and increases the sensitivity
for detecting DE of the more abundant transcripts [12].
Figure 3 illustrates those genes either DE or awarded a
high PIF score in at least one of the two transfections.
Immune and mitochondrial genes are highlighted based
on functional annotations performed by importing the
list into the DAVID web tool [18]. Immune genes and
nuclear-encoded mitochondrial genes are prominent
among the DE genes but the direction of change is not
consistent.
On the other hand, among the significant PIF tran-
scripts in the cells transfected with the long transcript
variant are three of the 13 mitochondrially-encoded
mitochondrial proteins (Mt-coxII, Mt-nd2 and Mt-nd4l).
Moreover, a deeper exploration shows that all the
mitochondrially-encoded genes represented on the array
(12 of the 13) display a coherent trend of upregulationbeta actin based on qRT-PCR of variant 1 and variant 3
Variant 3 construct Variant 1 construct B actin
31.93 (no amplification) 35.6 (no amplification) 23.16
19.41 34.19 (no amplification) 23.36
30.32 (no amplification) 29.19 23.10
lization. ‘No amplification’ denotes multiple dissociation peaks i.e. non-specific
Table 4 The top 10 most upregulated genes following transfection and expression of Rnf14 variant 3 and variant 1
transcripts in C2C12 cells
Rnf14 variant 3 versus controls Gene ontology Fold change (Log2)
Ifit3 Interferon induced protein 2.22
G1p2 Interferon induced protein 2.20
2510004L01Rik (RSAD2) Interferon inducible 2.09
Oasl2 2'-5'-oligoadenylate synthetase activity 1.97
2310061N23Rik (Ifi27l2a) Interferon inducible 1.96
Ccl5 Chemokine ligand 5 1.91
AI481100 (Irgm2) Interferon induced GTPase 1.84
Usp18 A member of the deubiquitinating protease family of enzymes 1.76
Rnf14 This protein interacts with androgen receptor (AR) and may function as a
coactivator that induces AR target gene expression
1.75
Gbp4 Induced by interferon and hydrolyzes GTP 1.73
Rnf14 variant 1 versus controls Gene ontology
Plac8 Placenta-specific, little known 2.07
G1p2 Interferon induced protein 1.99
Oasl2 2'-5'-oligoadenylate synthetase activity 1.82
Ccl5 Chemokine ligand 5 1.68
LOC223672 (Apol9a) Apolipoprotein, little known 1.65
2510004L01Rik Interferon inducible 1.61
2310016F22Rik (Apol9b) Apolipoprotein, little known 1.54
ifit3 Interferon induced protein 1.42
Gbp4 Guanylate-binding proteins induced by interferon 1.30
Oasl1 2'-5'-oligoadenylate synthetase activity 1.21
Genes may be represented by more than one probe. The controls are a combination of untransfected cells and cells transfected with an empty construct.
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probe (Figure 3; Table 6; Additional file 2). The standard
error bars for Figure 3 were calculated using the stand-
ard curve method [19]. A subset of these mitochond-
rially encoded genes that are significantly DE as assayed
in pairwise comparisons are also highlighted on Figure 2.
The upregulation of mitochondrially-encoded mitochon-
drial proteins was not observed in the Rnf14 variant 3
transfected cells (Additional file 2). The full list of DE
and differentially PIF genes can be found in Additional
file 3.
Motif analysis and bioinformatics
We next attempted to identify regulatory motifs that are
conserved among the RNF14 responsive genes in an at-
tempt to determine the cellular pathway linking Rnf14
upregulation to the observed mitochondrial and inflam-
matory output. Hunting for conserved Transcription
Factor Binding Sites 1000 bp upstream of the DE genes
using Whole Genome RVista for mouse, enriched for
Hfh3 in both the variant 1 (P = 9.29-log10) and variant 3
transfection experiments (P = 6.57-log10).
We also undertook a combination of bioinformatic
analyses and literature mining. A protein motif analysisof RNF14 within UNIPROTKB indicated the presence of
1) an N-terminal destruction box which could act as a
recognition signal for ubiquitin proteosome degradation
and 2) RING type zinc finger essential for interaction
with UBE2E2.
Discussion
In an attempt to infer the functional role of the RNF14
protein, previously found to be co-expressed with mito-
chondrial and immune genes in developing bovine long-
issimus muscle, we transfected each of two Rnf14
transcript variants into a mouse myoblast cell line. Inter-
estingly, and despite low expression levels of that tran-
script, transfection with transcript variant 1 culminated
in a significant upregulation in the transcription of three
of the 13 mitochondrially-encoded mitochondrial genes
(i.e. Mt-nd4L, Mt-coxII and Mt-nd2) [12]. Furthermore,
while we only have microarray expression data for 12 of
the 13 of these genes (Mt-coxI is missing) a deeper ex-
ploration shows that the remaining nine all display a
modest but coherent trend of upregulation. The direc-
tion of this observation is consistent with the initial net-
work connections being based on positive rather than
negative co-expression values. While the fold-change is
Table 5 The top 10 most downregulated genes following transfection and expression of Rnf14 variant 3 and variant 1
transcripts in C2C12 cells
Rnf14 variant 3 versus controls Gene ontology Fold change (Log2)
Dcn The encoded protein is a small cellular/pericellular matrix proteoglycan −1.96
Myl1 This gene encodes a fast myosin alkali light chain −1.76
Spon2 Extracellular matrix protein −1.63
Prelp The protein encoded by this gene is a leucine-rich repeat protein present in
connective tissue extracellular matrix
−1.57
Dcn The encoded protein is a small cellular or pericellular matrix proteoglycan −1.50
Mylk This gene, a muscle member of the immunoglobulin gene superfamily, encodes
myosin light chain kinase which is a calcium/calmodulin dependent enzyme
−1.24
Tgm2 Transglutaminases are enzymes that catalyze the crosslinking of proteins by
epsilon-gamma glutamyl lysine isopeptide bonds
−1.20
Tnnt1 This protein is the slow skeletal troponin T subunit −1.18
Htra3 Proteolysis −1.17
Mylpf Fast skeletal muscle −1.16
Rnf14 variant 1 versus controls Gene ontology
Dcn The encoded protein is a small cellular or pericellular matrix proteoglycan −0.88
Dcn The encoded protein is a small cellular or pericellular matrix proteoglycan −0.75
Myl1 This gene encodes a fast myosin alkali light chain −0.67
Prelp The protein encoded by this gene is a leucine-rich repeat protein present
in connective tissue extracellular matrix
−0.67
Spon2 Extracellular matrix, innate immune response −0.62
Col6a2 Collagens are extracellular matrix proteins and have a triple-helical domain −0.60
Enpp1 The encoded protein is a type II transmembrane glycoprotein −0.57
1190002H23Rik (Rgc32) Cell cycle −0.55
Islr Immunoglobulin superfamily containing leucine-rich repeat −0.54
C1qtnf3 (Cors) Beta oxidation, peroxisomal metabolism −0.53
Genes may be represented by more than one probe. The controls are a combination of untransfected cells and cells transfected with an empty construct.
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dantly expressed which provides a favourable signal to
noise ratio for reliable detection. The array does not re-
port on the 22 mitochondrially encoded tRNAs and two
ribosomal RNAs that make up the remaining transcrip-
tional output of the mammalian mitochondrion, which
encodes 37 different genes in total.
The expression of a number of nuclear-encoded mito-
chondrial proteins was also upregulated following trans-
fection of Rnf14 variant 1 (Figure 2). For example,
Cmpk2 (alias Tyki) (2.4-fold up regulated) is a nucleoside
monophosphate kinase that localises to the mitochon-
dria and has previously been found to be tightly corre-
lated with macrophage activation and inflammation [20].
A very recent publication has documented Rnf14 as a
positive regulator of canonical Wnt signalling in human
cells [21], with canonical Wnt signalling previously re-
ported to be a potent activator of mitochondrial biogen-
esis [22]. This recent body of work clearly complements
our findings linking Rnf14 with mitochondrial physiology.
While the broad transcriptional impact of Rnf14 vari-
ant 1 transfection on our samples was in line with ourfunctional prediction, there were some interesting devia-
tions. Firstly, the nuclear and mitochondrially-encoded
mitochondrial proteins occupy distinct parts of the ori-
ginal bovine muscle co-expression network [10]. While
Rnf14 sits in the nuclear-encoded portion of the in vivo
bovine network, transfection with variant 1 appears to
exert the most coherent transcriptional influence on the
mitochondrially-encoded mitochondrial proteins. By way
of contrast, Rnf14 variant 3 transfection did not lead to a
detectable change on the expression of mitochondrially-
encoded mitochondrial genes, despite an overabundance
of the variant 3 transcript in the variant 3 transfected
cells.
Both Rnf14 variants influenced expression of genes en-
coding proteins relating to immune function. Unlike the
mitochondrially-encoded mitochondrial proteins upreg-
ulated observed in Rnf14 variant 1 transfected cells,
genes belonging to inflammatory processes were both
up- and downregulated. Prominent among the perturbed
immune genes were chemokines (e.g. Ccl2, Ccl4, Ccl5,
Ccl7, Cxcl10, Cxcl12), interferon regulatory factors and
related interferon responsive and signalling genes (e.g.
Figure 2 The effect of transfection of the Rnf14 variant 1 and 3 transcripts on genome-wide gene expression in C2C12 cells. Panel A
Transfection of the Rnf14 transcript variant 1 on genome-wide gene expression supports a functional role in mitochondrial and immune function.
The significant upregulation of several mitochondrially encoded mitochondrial proteins is noteworthy. Panel B Transfection of Rnf14 transcript variant
3 on genome-wide gene expression supports a functional role in immune function. The Rnf14 probe reporting these data is ILMN_2675078.
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Adar, Gbp2). In humans following eccentric exercise, the
in vivo inflammatory response includes activation of
chemokines [23]. A number of these genes also imply
apoptosis, a mitochondrial phenomenon [24]. These data
go some way towards resolving the question posed by
our apparently ambiguous (i.e. strong co-expression to
both mitochondrial and immune genes) observations
from the bovine muscle co-expression network, and
imply that both mitochondrial and immune predictions
are supported, depending on the particular transcript
variant under consideration.
Both RNF14 motifs (N-terminal destruction box and
RING type zinc finger) indicate some involvement in
ubiquitin mediated proteolysis which ties in with apop-
tosis, and UBE2E2 is known to play a specific role in
adaptive immunity signalling. The motif analysis shows
that most of the large transcription factor motifs (Zincfingers and RNA binding domains) of the protein reside
in the C-terminus shared by both isoforms, while the
missing amino acids in the shorter isoform result in the
loss of an RWD domain. We hypothesise that the RWD
domain accounts for the mitochondrial response ob-
served after transfection with Rnf14 transcript variant 1.
Recent work has emphasised deep functional connec-
tions between mitochondria and innate immunity in
general [25,26], and mitochondria and antiviral process-
ing in particular [27], which is clearly of interest given
the very same dual roles outlined here for RNF14.
The downregulation of a set of extracellular region and
extracellular matrix transcripts following transfection with
both Rnf14 transcript variants was unexpected. Example
downregulated molecules common to both transfections
included multiple collagen isoforms (Col14a1, Col6a2,
Col6a1, Col8a2, Col16a1), other matrix structural compo-
nents (Dcn, Mglap) and matrix remodelers (Mmp2,
Figure 3 The effect of transfection with Rnf14 variant 1 on
gene expression of the mitochondrially-encoded mitochondrial
proteins. There are probes representing 12 of the 13 mitochondrially
encoded mitochondrial genes. At least one probe representing each
gene indicates a substantial trend of upregulation.
Table 6 The absolute expression levels of the
mitochondrially-encoded mitochondrial proteins in the







Mt-coxII* 15.19 ± 0.09 14.80 ± 0.20
Mt-coxII* 14.84 ± 0.09 14.45 ± 0.21
Mt-coxIII 15.78 ± 0.10 15.71 ± 0.03
Mt-atp6 14.76 ± 0.04 14.42 ± 0.23
Mt-atp6 15.75 ± 0.10 15.79 ± 0.03
Mt-atp8 15.48 ± 0.05 15.21 ± 0.15
Mt-cytB 15.66 ± 0.08 15.59 ± 0.08
Mt-cytB 15.87 ± 0.05 15.73 ± 0.04
Mt-nd1 15.51 ± 0.06 15.24 ± 0.13
Mt-nd1 15.93 ± 0.09 15.93 ± 0.01
Mt-nd2* 14.73 ± 0.06 14.29 ± 0.19
Mt-nd3 8.45 ± 0.17 8.16 ± 0.23
Mt-nd4 15.90 ± 0.06 15.84 ± 0.05
Mt-nd4 15.66 ± 0.07 15.54 ± 0.10
Mt-nd4l* 12.76 ± 0.16 12.28 ± 0.29
Mt-nd4l 11.37 ± 0.13 10.98 ± 0.37
Mt-nd5 12.52 ± 0.05 12.23 ± 0.25
Mt-nd6 7.92 ± 0.37 7.72 ± 0.23
Mt-nd5 7.94 ± 0.07 7.74 ± 0.17
*Denotes pairwise significant differences at the P < 0.01 level.
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phenomena. On the one hand, it may reinforce the trans-
mission of the immune signals we have observed, as it has
been documented that the extracellular matrix plays a cru-
cial role in the inflammatory process [28]. Alternatively,
the signal may correspond to differences in myocyte pro-
gression through proliferation and differentiation, the
transition through which is known to be accompanied by
various changes in matrix-mediated adhesion [29].
Interpreting the various lines of evidence linking
RNF14 protein to immune and mitochondrial functions
is complicated by the cross-species sources of data. The
original co-expression prediction of RNF14’s gene function
was made mainly from bovine expression data. Disentan-
gling the various pieces of information is challenging given
cattle are a non-model organism and we have incomplete
knowledge of bovine functional genomics. For example, it
is not clear how many bovine RNF14 transcript variants
exist in total, which clearly complicates our (co-expres-
sion) interpretation of the Agilent probe that provided the
original foundation for some of the predictions.
Nevertheless, the outcome of this validation experi-
ment supports three of our systems biology gene discov-
ery approaches: 1) Partial Correlation and Information
Theory (PCIT) [30] 2) Module-to-Regulator analysis [10]
and 3) Regulatory Impact Factors [12,13]. While there is
some overlap in the exact molecules present in the co-
expression modules and those perturbed in this subse-
quent transfection experiment (Prsmb8 and Irf1 being
common to both in an immune context), the overlap isvery patchy. This implies that predictions based on con-
siderations of co-expression or differential co-expression
are perhaps best made in terms of broad function rather
than specific molecules.
Conclusions
Rnf14, which encodes a transcriptional co-factor, acts via
two differentially spliced transcripts to modulate innate
immune responses, tissue energy homeostasis and the
tissue matrix. We do not know under what stimuli either
transcript is produced by cells of different lineages. We
have shown that gene expression information generated
in a non-model organism can be used to develop hy-
potheses that can be validated in more conventional sys-
tems. The validation of this approach enhances the
intrinsic value of many existing datasets generated in a
range of species as it provides a methodology for de-
tailed analysis of fundamental biological phenomena,
such as mitochondrial transcription and biogenesis. Fu-
ture work could aim to tease out whether one or more
of the RNF14 protein isoforms are mitochondrially co-
localised in addition to the mRNA transcripts being
mitochondrially co-expressed, and/or whether in vivo
evidence can be detected for a role in immune function
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ment the in vitro data we have presented.Methods
Prioritisation of RNF14 for experimental analysis
Three separate lines of evidence were used to make a
prediction of RNF14’s possible role in immune versus
mitochondrial function.
Firstly, a co-expression network on developing bovine
muscle samples - inferred using the PCIT algorithm –
connected RNF14 to a dense nuclear-encoded mitochon-
drial module (comprising the following with correlations
>0.85 MDH1, PDHA1, NDUFS2, ES1, UQCRC1, NDUFV1,
MDH2, GOT2, NDUFA9, SOD2, CYCS, NDUFV2, SDHA,
BRP44, ACO2, APOO) [10]. The position of RNF14 in the
mitochondrial module of the co-expression network made
a prediction about a role in mitochondrial function.
Secondly, a related co-expression based approach called
Module-to-Regulator Analysis performed on the same
data set showed that - in addition to its relationship to nu-
clear and mitochondrially-encoded genes - RNF14 also
had very high overall co-expression patterns to the mem-
bers of a separate immune module (IKZF3, PSMB9,
MYO1G, PSMB8, A_73_104252, GIMAP7, A_73_109561,
A_73_111087, CD48, A_73_110856, ASPA, IRF1, PTPN7,
BOLA-DRA, A_73_116074, CD3G, BOLA-DRB3 and
GIMAP6) [10] (Table 7).
Thirdly, application of the Regulatory Impact Factor
(RIF) algorithm to an entirely independent data set
(comparing high-mitochondrial content brown fat versus
low-mitochondrial content white fat) awarded high like-
lihood of phenotype causality to the RNF14 protein [13].Table 7 Top 10 transcriptional regulators showing the highes
bovine muscle immune module
Transcriptional regulator
(average correlation to immune module)
Gene ontology
IRF1 (0.905) IRF1 encodes interferon regulat
(IRF) family. IRF1 also functions
Further, IRF1 has been shown t
RNF14 (0.901) This protein interacts with and
target gene expression
TEAD1 (0.872) This gene encodes a ubiquitou
domain family
LRRFIP1 (0.849) Phosphorylated in response to
EPAS1 (0.845) Myoblast cell fate commitment
NR1D2 (0.844) Nuclear Hormone Receptor inv
RORC (0.841) Regulates IL2 expression. IL2 is
PCGF5 (0.840) Little known
PHF12 (0.838) Little known
HOXD8 (0.838) The homeobox genes encode
role in morphogenesisAmplification, cloning and transformation of two
transcript variants of RNF14
The mouse ortholog for RNF14 (GenBank accession
NM_020012.1) was identified through sequence align-
ment to the bovine RNF14 protein. Mouse muscle
cDNA was used as template for a PCR designed to amp-
lify the full length mRNA encoding the Rnf14 gene. To
increase recognition of the first ATG by the ribosome,
the forward primer incorporated the mammalian Kozak
sequence (CCATGG) prior to the start of the Open
Reading Frame. PCR primers also incorporated vector
sequence, restriction enzyme sites used for cloning (NcoI
at 5’ and XhoI 3’) and gene specific sequence. The forward
primer for PCR was 5'- GAGATATGCCACCATGGAGT
CGGCAGAAGACCTGGAAGCCCAG-3' and the reverse
primer 5'- GTGATGGTGGTGCTCGAGGTCGTCGTCG
TCGTCTTCATCATCGT-3'.
A conventional PCR with a 50°C annealing tempera-
ture using high fidelity Taq polymerase, amplified a band
of 1457 base pairs. This was gel purified and cloned into
the pTANDEM-1 vector (EMD4 Biosciences, Merck,
USA) using a fusion homologous recombination method.
The resultant expression plasmid contained a His6 tag at
the C terminus of the RNF14 gene for protein purification
and detection by antibodies.
In a separate PCR reaction a shorter Rnf14 transcript
variant was also amplified (1306 bp), using the forward
primer 5'-ATGTCGGCAGAAGACCTGGAAGC-3' and
the reverse primer 5'-CTAGTCGTCGTCGTCGTCTT
CATCATCG-3'. This PCR product was cloned into the
pcDNA3.1/V5-his TOPO TA vector (Invitrogen, USA).
The two variants are referred to as Rnf14 transcript
variant 1 and Rnf14 transcript variant 3. Followingt absolute, average co-expression to all the genes in the
ory factor 1, a member of the interferon regulatory transcription factor
as a transcription activator of genes induced by interferons α, β and γ.
o play roles in regulating apoptosis
rogen receptor (AR) and may function as a co-activator that induces AR
s transcriptional enhancer factor that is a member of the TEA/ATTS
immunologic stimuli
olved in carbohydrate and lipid metabolism
an inflammatory cytokine
a highly conserved family of transcription factors that play an important
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clones were picked and diagnosed for the presence of
the insert in the correct orientation using restriction di-
gests (XhoI and NcoI) followed by gel electrophoresis.
Clones predicted to contain the correct insert were se-
quenced from both ends of the expression construct
using the BGH, T7 and pTandem1 Tandem DOWN1
primer and aligned to the GenBank mouse RNF14
sequence.
Expression constructs containing the correct sequence
were midi-prepped (Qiagen) following the manufac-
turer’s instructions and stored at 1 μg/μl at −20°C in
preparation for transfection. The Qiagen midi-prepping
protocol removes LPS and provides transfection-ready
reagents.
A control construct containing no insert (hereon re-
ferred to as “empty”) was also produced and subse-
quently used for transfection. A separate control was
derived from untransfected cells.
Cell culture and transfection conditions
The murine myoblast cell line, C2C12, was obtained from
the American Type Culture Collection and cultured in
DMEM supplemented with penicillin/streptomycin and
10% fetal bovine serum. Transfection conditions for the
C2C12 cells (passage numbers 15 – 20) were explored for
a range of confluences and Lipofectamine 2000 (Invitro-
gen) transfection reagent: DNA ratios. A pEGFP.C3 vector
containing Green Fluorescent Protein (GFP) was used to
visualise transfection efficiency under a Zeiss AX10 fluor-
escence microscope fitted with an Axiocam camera. As
previously reviewed [31], we found that C2C12 cells trans-
fected with a low transfection efficiency of ~10%. Optimal
cell number was found to be 5 × 104 cells/well transfected
with 5 μl of Lipofectamine 2000 and 800 ng DNA per well
for 48 hours.
The experiment was run in two 24-well Geltrex-coated
plates using the optimised procedure. Cells were cultured
for 24 hours prior to transfection. At the time of transfec-
tion the cells were ~50% confluent. Two independent con-
trols were used, one with no transfection and the other
through transfection of the empty construct.
Twelve independent wells were run for each of the
four treatment groups (no transfection, empty construct,
Rnf14 short transcript variant and Rnf14 long transcript
variant) giving a 48 well cell culture experiment in total.
At 48 hours post transfection the cells from each well
were harvested for RNA, while a GFP transfection run
in parallel was fixed and stained to provide an estimate
of transfection efficiency.
RNA extraction and microarray hybridisation
Total RNA was independently extracted from each of the
48 cell culture wells using QIAshredder homogenates andQIAgen RNeasy columns (Qiagen), incorporating the on-
column DNase treatment (Ambion) to remove genomic
DNA contamination. RNA integrity and purity was
assayed visually by gel electrophoresis and additionally by
A260/280 spectrophotometry. All the RNA samples resolved
into discrete 16S and 26S ribosomal RNA bands.
Because each of the four treatment groups comprised
12 independent RNA samples, these 12 were pooled into
3 major groups of 4 replicates with each replicate con-
tributing 0.5 μg. This process yielded 12 by 2.0 μg
pooled RNA samples as follows (no transfection 1, no
transfection 2, no transfection 3, empty construct 1, empty
construct 2, empty construct 3, short transcript 1, short
transcript 2, short transcript 3, long transcript 1, long
transcript 2, long transcript 3).
The 12 RNA pools were submitted to the Gene Ex-
pression Centre at the University of Queensland’s Insti-
tute for Molecular Bioscience for cDNA synthesis and
hybridisation to the Illumina WG6 mouse microarray
platform. This facility performed an additional set of
quality checks based on possession of an RNA Integrity
Number (RIN) >8 assayed on a Bioanalyzer.
Statistical analysis
The analytical procedures to normalize the data and to
identify differentially expressed genes were based on
methods developed by our group and published else-
where. In particular, we followed the methodology de-
scribed in [15,32,33].
The raw data from the Illumina Microarray System
contained expression signals from 45,281 probes across
the 12 hybridizations.
Initial normalization
We base-2 Log-transformed the expression signals to
stabilize the variance, capturing only those probes with a
“detectable” signal (P < 0.01) in at least one of the 12 hy-
bridizations. This produced a “cleaned” dataset of 18,129
Illumina probes.
Chip normalization
The “cleaned” dataset was subject to a within chip
normalization in which each signal was normalized by
subtracting the within-chip mean and dividing by the
within-chip standard deviation. The chips were therefore
standardized to have a mean (μ) of 0 and a standard de-
viation (σ) of 1, enabling data from different chips to be
combined without the risk of being influenced by differ-
ences in mean or SD. This allows subsequent linear
functions to be more reasonably derived, in our case
computation of differential expression. The resulting
normalized dataset was subjected to hierarchical cluster
analyses using the PermutMatrix software [34].
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For the identification of DE/DPIF genes we focused on
two contrasts: variant 1 versus controls and variant 3
versus controls. Following [35] a two-component normal
mixture model was fitted to identify DE/DPIF genes. Pa-
rameters of the mixture model were estimated using the
EMMIX-GENE software [36] and an estimated experiment-
wise false discovery rate (FDR) of < 1% used as the thresh-
old for determining which genes are DE/DPIF.
qRT-PCR
We used Superscript III (Invitrogen) for cDNA synthesis
for the 12 pools following the manufacturer’s instruc-
tions, in each case using 1ug of the same RNA stock
hybridised to the microarray platforms. The resultant 20
ul of neat cDNA was diluted to make a 1:10 solution for
qPCR.
Four primer sets were designed to discriminate be-
tween endogenously produced and transfection con-
struct generated Rnf14 mRNA species (Table 2). In each
case, Primer3 software was used for primer design to
amplify 100–200 bp of sequence based on a 60°C an-
nealing temperature. We accepted the remainder of Pri-
mer 3’s default settings.
To assay expression all endogenous Rnf14 transcripts
we designed primers in the 3' UTR of exon 11 (Figure 1).
This exon is shared by all variants, but will not amplify
construct based transcripts because they possess vector
sequence downstream of the stop codon. To assay all
Rnf14 transcripts (endogenous and from the transfection
constructs) we designed primers in exons 7–8 that are
shared by all the mRNA species. To assay transcription
relating to the two expression constructs (forward pri-
mer visualised on Figure 1) we designed the forward pri-
mer prior to the stop codon in exon 11 and the reverse
primer in the downstream vector sequence.
For the qRT-PCR assays we used a Sybr Green master
mix with 900 nM of each primer and a constant amount
of cDNA run on an Applied Biosystems ViiA7 thermal
cycler (Forster City, CA, USA) in 10 μl reactions. qPCR
reactions were run in triplicate with a no template con-
trol for each primer set. Expression was normalised
using beta-actin as a reference gene. Because the empty
construct and untransfected cells could not be discrimi-
nated by microarray, we used the empty construct as the
control RNA’s for qRT PCR.
qRT PCR statistical analysis
Following previously described approaches [37] statis-
tical analysis was carried out using SAS software 9.2
(SAS Institute, Cary, NC), using triplicate Ct values per
sample. In particular the Ct values were normalized by
fitting an analysis of variance (ANOVA) model that
accounted for “within primer across treatment” and“within treatment across primer” variation. A general lin-
ear model approach was used consisting of the following:
Expression (Ct) ~ Primer +Treatment + Primer*Treatment +
Error. Finally, for each Primer, the corresponding contrast
of least-square means for Ct values in the Treatment of
interest was used to ascertain differential expression.Additional files
Additional file 1: The normalized mean expression values (log 2)
for all genes across the 12 biological replicates.
Additional file 2: The fold changes in the mitochondrially-encoded
mitochondrial proteins following Rnf14 transfection.
Additional file 3: Those genes significantly DE and DPIF following
Rnf14 transfection.
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